FRANCE: Deinove, a French biotech company that uses a disruptive approach to develop innovative antibiotics and bio-based active ingredients for cosmetics and nutrition, has announced a collaboration with Dow for the joint development of a cosmetic ingredient derived from its collection of bacterial extracts. Deinove owns a large bacterial collection that includes more than 6,000 rare strains, collected in many different biotopes (hot springs, volcanos, lagoons, beaches and caves) and on variou...